Matthew Scott Harris - Net Worth and Insider Trading
Matthew Scott Harris Net Worth
The estimated net worth of Matthew Scott Harris is at least $228,847 dollars as of 2025-01-12. Matthew Scott Harris is the Chief Medical Officer of Altimmune Inc and owns about 33,311 shares of Altimmune Inc (ALT) stock worth over $228,847. Details can be seen in Matthew Scott Harris's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew Scott Harris has not made any transactions after 2023-03-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Matthew Scott Harris
Matthew Scott Harris Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew Scott Harris owns 1 companies in total, including Altimmune Inc (ALT) .
Click here to see the complete history of Matthew Scott Harris’s form 4 insider trades.
Insider Ownership Summary of Matthew Scott Harris
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALT | Altimmune Inc | 2023-03-23 | Chief Medical Officer |
Matthew Scott Harris Latest Holdings Summary
Matthew Scott Harris currently owns a total of 1 stock. Matthew Scott Harris owns 33,311 shares of Altimmune Inc (ALT) as of March 23, 2023, with a value of $228,847.
Latest Holdings of Matthew Scott Harris
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALT | Altimmune Inc | 2023-03-23 | 33,311 | 6.87 | 228,847 |
Holding Weightings of Matthew Scott Harris
Matthew Scott Harris Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew Scott Harris has made a total of 2 transactions in Altimmune Inc (ALT) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Altimmune Inc is the acquisition of 10,000 shares on March 23, 2023, which cost Matthew Scott Harris around $42,200.
Insider Trading History of Matthew Scott Harris
- 1
Matthew Scott Harris Trading Performance
GuruFocus tracks the stock performance after each of Matthew Scott Harris's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Matthew Scott Harris is -6.68%. GuruFocus also compares Matthew Scott Harris's trading performance to market benchmark return within the same time period. The performance of stocks bought by Matthew Scott Harris within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Matthew Scott Harris's insider trading performs compared to the benchmark.
Performance of Matthew Scott Harris
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 38.19 | | | | | |
| Relative Return to S&P 500(%) | 33.51 | | | | | |
Matthew Scott Harris Ownership Network
Ownership Network List of Matthew Scott Harris
Ownership Network Relation of Matthew Scott Harris
Matthew Scott Harris Owned Company Details
What does Altimmune Inc do?
Who are the key executives at Altimmune Inc?
Matthew Scott Harris is the Chief Medical Officer of Altimmune Inc. Other key executives at Altimmune Inc include Chief Financial Officer Richard I Eisenstadt , Chief Business Officer Raymond M Jordt , and director & President and CEO Vipin K Garg .
Altimmune Inc (ALT) Insider Trades Summary
Over the past 18 months, Matthew Scott Harris made no insider transaction in Altimmune Inc (ALT). Other recent insider transactions involving Altimmune Inc (ALT) include a net sale of 15,711 shares made by David Drutz ,
In summary, during the past 3 months, insiders sold 0 shares of Altimmune Inc (ALT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 16,011 shares of Altimmune Inc (ALT) were sold and 300 shares were bought by its insiders, resulting in a net sale of 15,711 shares.
Altimmune Inc (ALT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Altimmune Inc Insider Transactions
Matthew Scott Harris Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew Scott Harris. You might contact Matthew Scott Harris via mailing address: C/o Altimmune, Inc., 910 Clopper Road, Suite 201s, Gaithersburg Md 20878.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
